Thomas P Mathews
Molecular Biology · 2014–2020
A researcher in the Science corpus: 2 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 21 citations into it
Whom Thomas P Mathews trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Thomas P Mathews's perspective
Ordered by how strongly the researchers Thomas P Mathews trusts endorse each paper. Same corpus, a different order for every researcher.
- G Protein-Coupled Receptor Allosterism and Complexing (Pharmacological Reviews)
- Allosteric binding sites on cell-surface receptors: novel targets for drug discovery (Nature reviews. Drug discovery)
- A new benzodiazepine pharmacology. (Journal of Pharmacology and Experimental Therapeutics)
- Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists. (Methods of biochemical analysis)
- MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo (Molecular Cancer Therapeutics)
- Protein kinases — the major drug targets of the twenty-first century? (Nature reviews. Drug discovery)
- Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders (Nature reviews. Drug discovery)
- Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system (Nature reviews. Drug discovery)
- Protein phosphorylation in signaling--50 years and counting. (TIBS -Trends in Biochemical Sciences. Regular ed)
- The specificities of protein kinase inhibitors: an update. (Biochemical Journal)
Their papers
- Drugs for allosteric sites on receptors. (2014) — 245 citations
- Lymph protects metastasizing melanoma cells from ferroptosis (2020) — 765 citations